3D INVESTOR ANIMATION
This Fusion Animation details bit.bio's revolutionary opti-ox™ technology for cell manufacturing. We used a minimalist style to show the cell as a computer, and how opti-ox overcomes gene silencing by inserting new programs into Genomic Safe Harbour sites. This proprietary method enables the deterministic, scalable manufacturing of pure human cells (e.g., ioGlutamatergic Neurons) for drug discovery and cell therapies. This showcases our expertise in Cell Reprogramming and Biotechnology
3D INVESTOR ANIMATION
This Fusion Animation details bit.bio's revolutionary opti-ox™ technology for cell manufacturing. We used a minimalist style to show the cell as a computer, and how opti-ox overcomes gene silencing by inserting new programs into Genomic Safe Harbour sites. This proprietary method enables the deterministic, scalable manufacturing of pure human cells (e.g., ioGlutamatergic Neurons) for drug discovery and cell therapies. This showcases our expertise in Cell Reprogramming and Biotechnology
3D DRUG DEVELOPMENT ANIMATION
This 3D animation by Fusion Animation details the Samsung Biologics CDO (Contract Development Organization) service to accelerate IND filing. The video visualizes the Bioprocess Development pipeline, including Cell Line Development, Upstream/Downstream optimization, and rigorous Analytical Method Development. It highlights reliable, cGMP-compliant manufacturing for clinical production. This showcases our expertise in animating detailed CDMO and Bioprocessing workflows across the Biotechnology sector.
3D DRUG DEVELOPMENT ANIMATION
This 3D animation by Fusion Animation details the Samsung Biologics CDO (Contract Development Organization) service to accelerate IND filing. The video visualizes the Bioprocess Development pipeline, including Cell Line Development, Upstream/Downstream optimization, and rigorous Analytical Method Development. It highlights reliable, cGMP-compliant manufacturing for clinical production. This showcases our expertise in animating detailed CDMO and Bioprocessing workflows across the Biotechnology sector.



















